Tendonitis Treatment Global Market Report 2024

The tendonitis treatment market has grown steadily in recent years. It will grow from $211.67 billion in 2023 to $219.73 billion in 2024 at a compound annual growth rate (CAGR) of 3.8%. The historical period's growth can be ascribed to advancements in pharmaceuticals, a rise in sports injuries, an aging population, occupational factors, and increased awareness and education.

The tendonitis treatment market is expected to see steady growth in the next few years. It will grow to $259.54 billion in 2028 at a compound annual growth rate (CAGR) of 4.3%. The anticipated growth in the forecast period is linked to factors such as government support and funding, the adoption of personalized medicine, the expansion of regenerative therapies, an increased demand for non-invasive treatments, and the prevalence of remote monitoring and telehealth. Notable trends expected in the forecast period include an emphasis on research and development, advancements in regenerative therapies, progress in physical therapy, a focus on minimally invasive treatments, and the utilization of telemedicine for remote consultations.

The anticipated growth in the tendonitis treatment market is expected to be propelled by the increasing prevalence of sports injuries. Sports injuries, involving muscles, tendons, ligaments, bones, and joints, occur during sports or physical activities. Tendonitis treatment for sports injuries typically involves a combination of rest, pain management, and physical therapy to facilitate tendon recovery, reduce swelling, and provide support to the affected area. For example, in June 2022, the National Safety Council reported that 3.2 million people sought treatment in emergency departments for injuries related to sports and recreational equipment. The number of such injuries increased by 20% in 2021, reaching 409,224 compared to 377,939 in 2020. Hence, the growing prevalence of sports injuries is a driving force for the tendonitis treatment market.

The rise in the global geriatric population is expected to contribute to the growth of the tendonitis treatment market. The geriatric population, typically aged 65 years or older, is witnessing an increasing incidence of tendonitis, necessitating advanced and effective treatment approaches tailored to address the specific needs of older individuals. As reported by the World Health Organization in October 2022, the global population of individuals aged 60 years is projected to reach 1.4 billion by 2030, compared to 1 billion in 2020. Moreover, it is estimated that 1 out of 6 people worldwide will be aged 60 years or older by 2030. Therefore, the growing global geriatric population is poised to drive the growth of the tendonitis treatment market.

Technological innovations represent a prominent trend gaining traction in the tendonitis treatment market. Companies within the market are embracing new technologies to maintain their competitive positions. For example, in September 2021, Stryker Corporation introduced the Citrelock Tendon Fixation Device System, designed to prevent bulk degradation and chronic inflammation during tendon implantation. Citrelock utilizes a tendon thread with a resorbable technology called Citregen, composed of citrate, calcium, and phosphate molecules essential for bone anatomy. This technology provides controlled and homogeneous resorption processes, preventing bulk degradation and chronic inflammation. Additionally, it offers strength comparable to cortical bone and modulus comparable to cancellous bone, ensuring fixation without causing tendon damage.

Major players in the tendonitis treatment market are intensifying their focus on introducing innovative implants, such as bioinductive implants, to gain a competitive advantage. Bioinductive implants stimulate the body's natural healing processes by providing a scaffold that promotes tissue regeneration. In July 2023, Smith & Nephew plc launched the REGENETEN bioinductive implant in India for rotator cuff repair. This implant supports the body's natural healing response, facilitating new tendon-such as tissue growth and altering the course of rotator cuff disease. Comprised of type 1 collagen, the implant offers an advanced healing solution for biological tendon regeneration across the spectrum of rotator cuff disease. About the size of a postage stamp, the implant is delivered arthroscopically through a small incision and disappears within six months, inducing the growth of new tendon-such as tissue and collagen orientation indicative of functional loading.

In April 2023, Vander-Bend Manufacturing, Inc., a US-based medical technology company, acquired Omni Components Corporation for an undisclosed amount. This acquisition is aimed at expanding Vander-Bend Manufacturing's manufacturing capabilities in the Northeast and Southwest. Omni Components Corporation is a US-based manufacturer and service provider of medical products specializing in spinal, cardiovascular, and tendon-related surgeries.

Major companies operating in the tendonitis treatment market report are Merck & Co. Inc., Bayer AG, Boehringer Ingelheim GmbH, Abbott Laboratories, Pfizer Inc., Almatica Pharma Inc., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Stryker Corporation, Colfax Corporation, Zimmer Biomet Holdings Inc., Össur hf, Tynor India Ltd., Arthrex Inc., CONMED Corporation, TendoMed Inc., BioPro Inc., Aevumed Inc., Alafair Biosciences Inc., AstraZeneca plc, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Boston Scientific Corporation, Wright Medical Group N.V., Breg Inc., Mueller Sports Medicine Inc., Bauerfeind AG, BSN medical GmbH, Henry Schein Inc.

North America was the largest region in the tendonitis treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global tendonitis treatment market report during the forecast period. The regions covered in the tendonitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tendonitis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of tendonitis treatments include rest, hot and cold therapy, physical therapy, shockwave therapy, and surgical interventions. Therapeutic therapy encompasses a diverse range of processes focused on promoting healing and addressing specific issues. In tendonitis treatment, therapeutic therapy includes various interventions such as steroids, surgery, and physical therapies to diminish inflammation and alleviate pain. Common types of tendonitis conditions include tennis elbow, golfer's elbow, pitcher's elbow, jumper's knee, swimmer's shoulder, and Achilles tendonitis. These treatments are utilized across different end-users, including hospitals, specialty clinics, home healthcare, and others.

The tendonitis treatment market research report provides tendonitis treatment market statistics, including tendonitis treatment industry global market size, regional shares, competitors with a tendonitis treatment market share, detailed tendonitis treatment market segments, market trends and opportunities, and any further data you may need to thrive in the tendonitis treatment industry. This tendonitis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tendonitis treatment market includes revenues earned by entities by providing various treatment to relieve pain and reduce irritation in tendinitis such as pain relivers, steroids, platelet rich-plasma, dry needling, compression and elevation, bracing and splinting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.